Bixiye
P34-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1711 - 1720 ee natiijooyinka 3167
Bixiye
P35-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
2023 May Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
Credentialing Policy Manual (PDF)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 21, 2023
Bixiye
QP27-23 Commercial and MHCP Pharmacy Benefit Exclusion for Syfovre™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP28-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP34-23 Update for New to Market Medical Drugs: Tofersen
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP35-23 Notice of Correction to Ambulance Mileage Reimbursement
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP29-23 Blue Cross Preferred Genetic Laboratory Program
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP30-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023